Noninvasive prenatal diagnosis based on cell‐free DNA for tuberous sclerosis: A pilot study

BACKGROUND: Noninvasive prenatal diagnosis (NIPD) based on cell‐free DNA (cfDNA) has been introduced into the clinical application for some monogenic disorders but not for tuberous sclerosis (TSC) yet, which is an autosomal dominant disease caused by various variations in TSC1 or TSC2 gene. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiao‐Yan, Meng, Yan, Wang, Yang‐Yang, Lu, Yan‐Ping, Wang, Qiu‐Hong, You, Yan‐Qin, Xie, Xiao‐Xiao, Bai, Ling, Fang, Nan, Zou, Li‐Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266619/
https://www.ncbi.nlm.nih.gov/pubmed/35429229
http://dx.doi.org/10.1002/mgg3.1952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266619/
https://www.ncbi.nlm.nih.gov/pubmed/35429229
http://dx.doi.org/10.1002/mgg3.1952

Ejemplares similares